Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma

被引:29
|
作者
Zhao, Chunling [1 ]
Gong, Lei [2 ]
Li, Wentong [1 ]
Chen, Limei [1 ]
机构
[1] Weifang Med Univ, Basic Med Dept, Weifang 261053, Shandong, Peoples R China
[2] Shandong Univ, Sch Med, Jinan, Shandong, Peoples R China
关键词
Plk1; Overexpression; ESCC; Small interfering RNA; Proliferation; Migration; POLO-LIKE-KINASE; CANCER-CELLS; PROGNOSTIC-SIGNIFICANCE; LUNG-CANCER; CYCLIN B1; EXPRESSION; APOPTOSIS; INHIBITION; ACTIVATION; GROWTH;
D O I
10.1007/s00432-009-0630-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Plk1, belonging to a family of serine/threonine kinases, is involved in spindle formation and chromosome segregation during mitosis and therefore, in the regulation of cell cycle. Plk1 was found to be overexpressed in various human tumors. In the present work, we investigated the expression of human esophageal squamous cell carcinoma (ESCC) to determine whether Plk1 has a role in malignant progress. Immunohistochemistry and Western blotting were performed to define the expressions of Plk1 in ESCC tissues and normal adjacent tissues. Transfection of cells with small interference RNA, growth suppression assay, and Transwell assay were used to determine the potential role of Plk1 in ESCC malignant progress. Plk1 was overexpressed in 69.6% of the ESCC tissues. In addition, the extent of Plk1 expression was closely correlated with differentiation grades and invasiveness in ESCC. We also found that the downregulation of endogenous Plk1 in human ESSC cell lines Eca-109 and EC9706 significantly decreased cells proliferation and migrating ability. Our results show that Plk1 expression is elevated in ESCC tissues and is associated with differentiation grades and invasiveness in ESCC, indicating that overexpression of Plk1 may play an important role in carcinogenesis and malignant progress of ESCC.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 50 条
  • [1] Overexpression of Plk1 promotes malignant progress in human esophageal squamous cell carcinoma
    Chunling Zhao
    Lei Gong
    Wentong Li
    Limei Chen
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 9 - 16
  • [2] Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma
    Feng, Yan-Bin
    Lin, De-Chen
    Shi, Zhi-Zhou
    Wang, Xiao-Chun
    Shen, Xiao-Ming
    Zhang, Yu
    Du, Xiao-Li
    Luo, Man-Li
    Xu, Xin
    Han, Ya-Ling
    Cai, Yan
    Zhang, Zi-Qiang
    Zhan, Qi-Min
    Wang, Ming-Rong
    INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) : 578 - 588
  • [3] Downregulation of PLK1 by RNAi attenuates the tumorigenicity of esophageal squamous cell carcinoma cells via promoting apoptosis and inhibiting angiogenesis
    Zhao, C. L.
    Ju, J. Y.
    Gao, W.
    Yu, W. J.
    Gao, Z. Q.
    Li, W. T.
    NEOPLASMA, 2015, 62 (05) : 748 - 755
  • [4] PLK1 regulating chemoradiotherapy sensitivity of esophageal squamous cell carcinoma through pentose phosphate pathway/ferroptosis
    Zhao, Mengnan
    Lu, Tao
    Bi, Guoshu
    Hu, Zhengyang
    Liang, Jiaqi
    Bian, Yunyi
    Feng, Mingxiang
    Zhan, Cheng
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 168
  • [5] Prdx1 promotes the loss of primary cilia in esophageal squamous cell carcinoma
    Chen, Qiongzhen
    Li, Jinmeng
    Yang, Xiaoning
    Ma, Junfeng
    Gong, Fanghua
    Liu, Yu
    BMC CANCER, 2020, 20 (01)
  • [6] Overexpression of OTX1 promotes tumorigenesis in patients with esophageal squamous cell carcinoma
    Chai, Jia
    Xu, Tianqi
    Yang, Yanru
    Yuan, Yuan
    Xu, Junpeng
    Liu, Jin
    Wang, Kaijing
    Lv, Yao
    Chai, Jialin
    Kang, Yulin
    Chen, Ligang
    Qin, Junhui
    Jia, Qingge
    Li, Mingyang
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 232
  • [7] The antitumor effect of PLK1 and HSF1 double knockdown on human oral carcinoma cells
    Kim, Soo-A
    Kwon, Seong-Min
    Yoon, Jung-Hoon
    Ahn, Sang-Gun
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2010, 36 (04) : 867 - 872
  • [8] Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma
    Liu, Ting-Ting
    Yang, Kai-Xia
    Yu, Jing
    Cao, Ying-Ya
    Ren, Jian-Song
    Hao, Jia-Jie
    Pan, Bei-Qing
    Ma, Sai
    Yang, Li-Yan
    Cai, Yan
    Wang, Ming-Rong
    Zhang, Yu
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2018, 96 (08): : 807 - 817
  • [9] Overexpression of leucine aminopeptidase 3 contributes to malignant development of human esophageal squamous cell carcinoma
    Zhang, Shu
    Yang, Xiaojing
    Shi, Hui
    Li, Mei
    Xue, Qun
    Ren, Hanru
    Yao, Li
    Chen, Xueyu
    Zhang, Jianguo
    Wang, Huijie
    JOURNAL OF MOLECULAR HISTOLOGY, 2014, 45 (03) : 283 - 292
  • [10] MiR-126 promotes esophageal squamous cell carcinoma via inhibition of apoptosis and autophagy
    Li, Mingli
    Meng, Xiangli
    Li, Mingxuan
    AGING-US, 2020, 12 (12): : 12107 - 12118